Overview

A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study how the body processes digoxin and the effect of dulaglutide on how digoxin is processed by the body. Information about any side effects that may occur will also be collected. This study is for research purposes only and is not intended to treat any medical condition. This research study requires that a blood sample be obtained and stored for future research involving genetic analysis.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Digoxin
Dulaglutide
Immunoglobulin Fc Fragments